Bioassays reveal potent insecticidal effects against Plutella xylostella and Mythimna separata, suggesting novel RyRs targeting.
The ryanodine receptors (RyRs) represent an optimal target for insecticide development. To explore novel structures of RyRs agonists, a series of compounds containing 1,2,4-oxadiazole were designed and synthesized based on the RyRs structure. The compounds were confirmed by 1H and 13C nuclear magnetic resonance as well as high-resolution mass spectrometry. Additionally, bioassays demonstrated that the majority of the newly synthesized compounds exhibited complete mortality (100%) against Plutella xylostella and Mythimna separata at a concentration of 50 mg/L. Furthermore, compound II5 showed a slightly higher LC50 value (LC50 = 0.20 mg/L) compared to the control chlorantraniliprole (LC50 = 0.06 mg/L) against M. separata. Through the toxicity study of the target compounds on Spodoptera frugiperda carrying the resistant mutant RyR (I4790M), it was confirmed that these target compounds have a similar mode of action to chlorantraniliprole. Moreover, the binding modes of these compounds were investigated, revealing that 1,2,4-oxadiazole serves as an effective substitute structure for amide bonds. These findings provide valuable insights for further structural optimization.
No takes yet. Share an insight, caveat, or question.
Du et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: